BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3685783)

  • 1. Auditory evoked potentials (AEPs), early (BAEPs) and long latency components (LLCs) in Parkinson's disease: a 12 month follow-up study.
    Bindi A; Russo G; Benvenuti F; Bandinelli S; Ferrucci L; Rossi L
    Riv Neurol; 1987; 57(4):245-50. PubMed ID: 3685783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of levodopa plus carbidopa on evoked potentials in Parkinson's disease.
    Cosi V; Romani A; Callieco R; Zerbi F
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):603-9. PubMed ID: 6712828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinson disease and cognitive evoked potentials].
    Gil R; Neau JP; Toullat G; Rivasseau-Jonveaux T; Lefèvre JP
    Rev Neurol (Paris); 1989; 145(3):201-7. PubMed ID: 2749097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M; Nouzeilles MI; Arce GP; Leiguarda R
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brainstem auditory evoked potentials and somatosensory evoked potentials in cerebral malaria--a prognostic significance.
    Kochar DK; Kumawat BL; Halwai M; Kochar SK; Shubhakaran ; Thanvi I
    J Assoc Physicians India; 2000 Mar; 48(3):295-300. PubMed ID: 11229113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease. Clinical and electrophysiological evaluation.
    Al-Bunyan MA
    Saudi Med J; 2000 Jan; 21(1):72-5. PubMed ID: 11533754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Auditory event-related potentials in Parkinson's disease].
    Zhoa ZY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):158-9, 188. PubMed ID: 1889326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory brainstem responses in patients under treatment of hemodialysis.
    Aspris AK; Thodi CD; Balatsouras DG; Thodis ED; Vargemezis V; Danielides V
    Ren Fail; 2008; 30(4):383-90. PubMed ID: 18569911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cortical and subcortical dementia. The value of long auditory evoked potentials].
    Gallois P; Hautecoeur P; Barbaste P; Chatelet P; Dereux JF
    Acta Neurol Belg; 1989; 89(3-4):253-7. PubMed ID: 2516974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The electroretinogram and visual evoked potentials in patients with Parkinson's disease].
    Burguera JA; Vilela C; Traba A; Ameave Y; Vallet M
    Arch Neurobiol (Madr); 1990; 53(1):1-7. PubMed ID: 2393335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs.
    Prabhakar S; Syal P; Srivastava T
    Neurol India; 2000 Sep; 48(3):239-42. PubMed ID: 11025627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease.
    Lukhanina EP; Kapustina MT; Berezetskaya NM; Karaban IN
    Clin Neurophysiol; 2009 Oct; 120(10):1852-8. PubMed ID: 19767236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
    Rascol O; Brooks DJ; Brunt ER; Korczyn AD; Poewe WH; Stocchi F
    Mov Disord; 1998 Jan; 13(1):39-45. PubMed ID: 9452324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
    Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.